Surya Laboratories Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 09-12-2024
- Paid Up Capital ₹ 5.00 M
as on 09-12-2024
- Company Age 36 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 Cr
as on 09-12-2024
- Satisfied Charges ₹ 3.78 Cr
as on 09-12-2024
- Revenue -63.24%
(FY 2022)
- Profit 959.49%
(FY 2022)
- Ebitda -191.66%
(FY 2022)
- Net Worth 11.32%
(FY 2022)
- Total Assets -42.39%
(FY 2022)
About Surya Laboratories
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹4.00 Cr. The company has closed loans amounting to ₹3.78 Cr, as per Ministry of Corporate Affairs (MCA) records.
Arun Kumar, Pooja Gupta, and Raghav Gupta serve as directors at the Company.
- CIN/LLPIN
U52311DL1988PTC278280
- Company No.
278280
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Nov 1988
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Social Media-
Who are the key members and board of directors at Surya Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Kumar  | Director | 01-Dec-2008 | Current |
| Pooja Gupta | Director | 14-Dec-2020 | Current |
| Raghav Gupta | Director | 16-Feb-2021 | Current |
Financial Performance of Surya Laboratories.
Surya Laboratories Pvt Ltd, for the financial year ended 2022, experienced significant reduction in revenue, with a 63.24% decrease. The company also saw a substantial improvement in profitability, with a 959.49% increase in profit. The company's net worth Soared by an impressive increase of 11.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Surya Laboratories?
In 2022, Surya Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 15 Oct 2022 | ₹4.00 Cr | Open |
Central Bank Of India Creation Date: 25 Nov 2014 | ₹1.00 Cr | Satisfied |
Canara Bank Creation Date: 02 Dec 2003 | ₹4.90 M | Satisfied |
How Many Employees Work at Surya Laboratories?
Surya Laboratories has a workforce of 2 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Surya Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surya Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
